ADMA ADMA Bio Year-over-year net earnings per share growth for the last 12 months
ADMA Biologics is implementing advanced screening methods to create targeted immunoglobulins. Quarterly earnings per share dynamics allow for an assessment of the business's fundamental stability, where the value 48.80 describes the current level. ADMA Biologics controls the entire production cycle of medications for patients with immunodeficiency. Currently, plants are operating at maximum capacity while simultaneously expanding the network of plasma collection centers.
ADMA (ADMA Corp): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital ADMA Biologics|ADMA - Long-Term Debt to Capital|Short-Term Debt to Capital ADMA Biologics|ADMA - Company Aggregate Debt|Debt to Book Capitalization Ratio ADMA Bio|ADMA - Company Long-Term Liabilities|Company Short-Term Debts ADMA Biologics|Quick Liquidity Indicator admabiologics.com
- earnings and market multiples details:
ADMA - Final Profit|Projected Future Earnings ADMA Biologics|ADMA - Price to Earnings Ratio|Forward P/E Multiple ADMA Bio|ADMA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ADMA Bio|ADMA - Profit before interest, taxes and amortization|Earnings per share for the last twelve months ADMA Biologics|ADMA - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months admabiologics.com|ADMA - Earnings per share growth rate in current year|Earnings growth forecast for next year ADMA Biologics
Summary company analysis:ADMA Biologics
Quarterly EPS growth measures the dynamics of net profit per share relative to the same period last year. By analyzing the percentage of quarterly EPS change, an investor assesses the business scaling speed and capital management efficiency. The metric is calculated as the ratio of the difference between the current and base values to the base value. A positive trend confirms the commercial viability of ADMA Biologics (ADMA). The effective expansion of plasma centers has provided the company with a stable transition to sustainable profitability.
Main competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth Protagonist Corp|Year-over-year earnings per share growth for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth GRFS (Grifols)|Adaptive Biotech (ADPT) - Earnings per share growth in annualized terms for the last twelve months|Celldex - Quarterly EPS earnings growth|AUPH - Quarterly EPS earnings growth|BCRX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VERA|Year-over-year earnings per share growth for the last twelve months Dianthus Therapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months Pharvaris NV (PHVS)|Quarterly EPS earnings growth ABCL|Quarterly EPS earnings growth Tourmaline (TRML)|Precigen, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PHAR|Nektar Therapeutics Inc. - Quarterly EPS earnings growth|UPB: Year-over-year earnings per share growth for the last twelve months|ZBIO: Quarterly EPS earnings growth|IMNM - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Gossamer Bio, Inc.|Earnings per share growth in annualized terms for the last twelve months kalvista.com KALV|Year-over-year earnings per share growth for the last twelve months Septerna (SEPN)|Year-over-year earnings per share growth for the last twelve months PVLA (Pieris Pharma)|Year-over-year earnings per share growth for the last twelve months Savara Corp SVRA|Rigel Corp (RIGL) - Earnings per share growth in annualized terms for the last twelve months|AnaptysBio, Inc. - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year astriatx.com (ATXS)|ENGN: Quarterly EPS earnings growth|RAPT - Year-over-year net earnings per share change for the last twelve months|JBIO (Aerovate Therapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Aclaris Therapeutics, Inc (ACRS)|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months tizianalifesciences.com|Quarterly EPS earnings growth CABA (Cabaletta Bio)|Quarterly EPS earnings growth Ventyx Biosciences Inc. VTYX|Theratechnologies Inc - Quarterly EPS earnings growth|AVTX (Avalo Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|Eledon Pharmaceuticals (ELDN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months agenusbio.com|CLYM (Climb Bio) - Quarterly EPS earnings growth|Quarterly EPS earnings growth zurabio.com|Year-over-year earnings per share growth for the last twelve months aTyr (ATYR)|ADAG: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth IMA (Ikena Oncology)|Year-over-year earnings per one share growth for the last 12 months STTK|Equillium Bio - Quarterly EPS earnings growth|CNTB - Quarterly EPS earnings growth|immunic-therapeutics.com (IMUX) - Year-over-year earnings per share growth for the last twelve months|Atara Bio - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months InflaRx NV|Year-over-year net earnings per share growth for the last 12 months x4pharma.com (XFOR)|Quarterly EPS earnings growth ACET|Quarterly EPS earnings growth celularity.com (CELU)|INmune Bio Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months BRNS|Kezar Life Sciences - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months sabbiotherapeutics.com SABS|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Enlivex Therapeutics Ltd.|Year-over-year earnings per share growth for the last twelve months Q32 Bio Inc|Year-over-year net earnings per share growth for the last 12 months GeoVax Corp (GOVX)|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech, Inc.)|Quarterly EPS earnings growth ibioinc.com (IBIO)|Year-over-year earnings per share growth for the last twelve months Carisma Therapeutics Inc. CARM|XTLB: Year-over-year earnings per share growth for the last 12 months|Bolt Bio - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months HCW Biologics Inc.|APVO: Quarterly EPS earnings growth|aimimmuno.com (AIM) - Quarterly EPS earnings growth|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GRI (GRI Bio Inc)|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Quarterly EPS earnings growth REVB (Revelation Biosciences)|Quarterly EPS earnings growth indaptusrx.com INDP|SCNI: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months CALI (CalciMedica, Inc.)|AFMD: Quarterly EPS earnings growth|ALLK (Allakos) - Year-over-year earnings per share growth for the last twelve months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|IGM Bio (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|Third Harmonic Bio Inc - Year-over-year earnings per share growth for the last twelve months
